BMRN
Price
$54.30
Change
+$0.41 (+0.76%)
Updated
Dec 3, 04:59 PM (EDT)
Capitalization
10.57B
84 days until earnings call
Intraday BUY SELL Signals
FTRE
Price
$14.59
Change
+$1.84 (+14.43%)
Updated
Dec 3, 04:59 PM (EDT)
Capitalization
1.15B
Intraday BUY SELL Signals
Interact to see
Advertisement

BMRN vs FTRE

Header iconBMRN vs FTRE Comparison
Open Charts BMRN vs FTREBanner chart's image
BioMarin Pharmaceutical
Price$54.30
Change+$0.41 (+0.76%)
Volume$54K
Capitalization10.57B
Fortrea Holdings
Price$14.59
Change+$1.84 (+14.43%)
Volume$18.01K
Capitalization1.15B
BMRN vs FTRE Comparison Chart in %
BMRN
Daily Signal:
Gain/Loss:
FTRE
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
BMRN vs. FTRE commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMRN is a Hold and FTRE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 04, 2025
Stock price -- (BMRN: $53.89 vs. FTRE: $12.75)
Brand notoriety: BMRN and FTRE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BMRN: 27% vs. FTRE: 26%
Market capitalization -- BMRN: $10.57B vs. FTRE: $1.15B
BMRN [@Biotechnology] is valued at $10.57B. FTRE’s [@Biotechnology] market capitalization is $1.15B. The market cap for tickers in the [@Biotechnology] industry ranges from $107.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BMRN’s FA Score shows that 0 FA rating(s) are green whileFTRE’s FA Score has 1 green FA rating(s).

  • BMRN’s FA Score: 0 green, 5 red.
  • FTRE’s FA Score: 1 green, 4 red.
According to our system of comparison, FTRE is a better buy in the long-term than BMRN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BMRN’s TA Score shows that 5 TA indicator(s) are bullish while FTRE’s TA Score has 5 bullish TA indicator(s).

  • BMRN’s TA Score: 5 bullish, 2 bearish.
  • FTRE’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, BMRN is a better buy in the short-term than FTRE.

Price Growth

BMRN (@Biotechnology) experienced а -4.26% price change this week, while FTRE (@Biotechnology) price change was -0.23% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +1.23%, and the average quarterly price growth was +54.93%.

Reported Earning Dates

BMRN is expected to report earnings on Feb 25, 2026.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BMRN($10.6B) has a higher market cap than FTRE($1.15B). BMRN YTD gains are higher at: -18.013 vs. FTRE (-31.635). BMRN has higher annual earnings (EBITDA): 934M vs. FTRE (-858.4M). BMRN has more cash in the bank: 1.43B vs. FTRE (81.2M). BMRN has less debt than FTRE: BMRN (604M) vs FTRE (1.24B). BMRN has higher revenues than FTRE: BMRN (3.06B) vs FTRE (2.73B).
BMRNFTREBMRN / FTRE
Capitalization10.6B1.15B921%
EBITDA934M-858.4M-109%
Gain YTD-18.013-31.63557%
P/E Ratio20.46N/A-
Revenue3.06B2.73B112%
Total Cash1.43B81.2M1,764%
Total Debt604M1.24B49%
FUNDAMENTALS RATINGS
BMRN: Fundamental Ratings
BMRN
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
64
PRICE GROWTH RATING
1..100
57
P/E GROWTH RATING
1..100
92
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BMRNFTRE
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 6 days ago
69%
Bearish Trend 6 days ago
89%
Momentum
ODDS (%)
Bullish Trend 6 days ago
58%
Bullish Trend 6 days ago
77%
MACD
ODDS (%)
Bullish Trend 6 days ago
57%
Bullish Trend 6 days ago
71%
TrendWeek
ODDS (%)
Bullish Trend 6 days ago
56%
Bullish Trend 6 days ago
75%
TrendMonth
ODDS (%)
Bullish Trend 6 days ago
53%
Bullish Trend 6 days ago
77%
Advances
ODDS (%)
Bullish Trend 9 days ago
58%
Bullish Trend 9 days ago
75%
Declines
ODDS (%)
Bearish Trend 14 days ago
62%
Bearish Trend 21 days ago
84%
BollingerBands
ODDS (%)
N/A
Bearish Trend 6 days ago
90%
Aroon
ODDS (%)
N/A
Bullish Trend 6 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BMRN
Daily Signal:
Gain/Loss:
FTRE
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FTTNX12.77N/A
N/A
Fidelity Advisor Asset Manager 30% M
FKEMX48.94N/A
N/A
Fidelity Emerging Markets K
BWLCX25.50N/A
N/A
American Beacon Man Lg Cp Value C
EGORX20.96N/A
N/A
Allspring Large Cap Core R6
GVALX15.42N/A
N/A
Gotham Large Value Institutional

BMRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, BMRN has been loosely correlated with TECH. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if BMRN jumps, then TECH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMRN
1D Price
Change %
BMRN100%
-2.07%
TECH - BMRN
55%
Loosely correlated
-1.32%
BEAM - BMRN
48%
Loosely correlated
-2.83%
SYRE - BMRN
47%
Loosely correlated
-0.91%
JAZZ - BMRN
45%
Loosely correlated
-3.17%
IRON - BMRN
45%
Loosely correlated
-2.16%
More

FTRE and

Correlation & Price change

A.I.dvisor indicates that over the last year, FTRE has been loosely correlated with TECH. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if FTRE jumps, then TECH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FTRE
1D Price
Change %
FTRE100%
+2.49%
TECH - FTRE
45%
Loosely correlated
-1.32%
BEAM - FTRE
43%
Loosely correlated
-2.83%
SYRE - FTRE
41%
Loosely correlated
-0.91%
BMRN - FTRE
40%
Loosely correlated
-2.07%
XNCR - FTRE
39%
Loosely correlated
-3.15%
More